NCT05502250 2026-03-06HOVON164HLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 2 Active not recruiting75 enrolled
NCT05498220 2025-09-02Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting5 enrolled